A single dose of 10 mg/kg CUSP06 significantly regressed the tumor growth in a CDH6-high, PARP inhibitor-resistant ovarian PDX model (LD1-1588, CDH6 H-score = 280) compared to isotype-ADC control (p < 0.05). The gene discussed is PARP1; the disease is neoplasm.